Kaustubh Kale
- Role
- Founder & CEO at Aventusoft Llc
- Location
- Boca Raton, FL, US
- LinkedIn followers
- 500 followers
About Kaustubh Kale
Kaustubh Kale is the Founder and CEO of Aventusoft, a medical research company that is…
Experience
Founder & CEO
Aug 2013 — Present · Boca Raton, FL, US
Founded Aventusoft with a mission to make a difference for patients with chronic diseases, through breakthrough medical innovations! With a focus to revolutionize structural heart health monitoring in the coming decade; combining biologically inspired hardware and software; with AI and Cloud Computing. We proudly invented the award-winning HEMOTAG Vitals technology. The industries first and only quad sensing technology that is advancing structural heart health vitals, the same way that multi-lead ECG vitals transformed the landscape for electrical heart health. Find out more at the degree of decongestion among patients with acutely decompensated heart failure, by simply performing a 30-second test; when it would take hours to get the same vitals from catheterization or blood draws. HEMOTAG Vitals is available for adult use in the US. Currently being used by clinical partners at #1 ranked hospitals. Won multiple national awards and secured funding for the R&D from the National Science Foundation, National Library of Medicine, National Institute on Minority Health and Health Disparities, National Institute on Disability and Rehabilitation Research, National Heart Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Defense Advanced Research Projects Agency, and US-ARMY.Want to make a difference? Send me your CV. We are hiring!
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.